|
시장보고서
상품코드
2008863
유방 병변 위치특정법 시장 보고서 : 유형별, 용도별, 최종사용자별, 지역별(2026-2034년)Breast Lesion Localization Methods Market Report by Type, Usage, End User, and Region 2026-2034 |
||||||
세계의 유방 병변 위치특정법 시장 규모는 2025년에 14억 3,680만 달러에 달했습니다. 향후 IMARC Group은 2034년까지 시장 규모가 30억 1,080만 달러에 달하고, 2026년부터 2034년까지 CAGR 8.30%로 성장할 것으로 예측했습니다.
유방 병변 위치특정법이란 질병이나 외상으로 인한 유방 조직의 비정상적인 변화(유방 병변이라고도 함)를 감지하기 위해 사용되는 다양한 방법을 말합니다. 일반적으로 사용되는 방법으로는 와이어 정위법, 카본 마킹법, 방사선 유도 은닉 병변 정위법(ROLL), 방사성 종자 정위법(RSL), 자기 종자 정위법(Magseed), 수술 중 초음파(IOUS) 등이 있습니다. 이러한 기술은 의사와 의료진이 환자에게 가장 적합한 치료법이나 수술을 결정하는 데 도움이 될 수 있습니다. 수술, 영상 진단 및 바이오메디컬 기술의 발전과 함께 유방 병변의 위치 확인 방법이 크게 발전하고 있으며, 이는 현재 의료 분야의 수요를 주도하고 있습니다.
유방 병변 위치특정법 시장 동향:
생활습관의 변화와 건강에 해로운 식습관으로 인해 유방암 환자가 크게 증가하면서 시장 성장을 견인하는 주요 요인으로 작용하고 있습니다. 이와 더불어, 종양 보존 수술이나 외과적 생검이 필요한 환자 수가 증가함에 따라 표적 병변을 정확하게 절제하기 위한 유방 병변 위치 확인 방법에 대한 수요가 증가하고 있습니다. 또한, 각국 정부 기관은 유방암 조기 발견의 이점에 대한 인식 개선을 위해 적극적인 노력을 기울이고 있습니다. 예를 들어, 호주 정부는 50세에서 74세 사이의 여성에게 2년마다 무료 유방암 검진을 제공하는 전국적인 유방암 검진 프로그램인 'BreastScreen Australia'를 시작했습니다. 여기에 유방암 진단, 생검 및 기타 관련 의료 절차에 대한 공공 및 민간 보험 적용 범위가 확대되고, 주요 기업들이 혁신적인 유방 병변 정위 장치를 출시하면서 시장 성장을 촉진하고 있습니다. 또한, 연구개발 활동에 대한 막대한 투자로 인해 시장 진입 기업에게 유리한 비즈니스 기회를 제공하고 있습니다. 또한, 유방 보형물 등 성형수술 인구 증가, 의료 인프라 개선, 기술 발전, 소비자의 의료비 지출 증가 등 다른 요인들도 시장 전망을 밝게 하고 있습니다.
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 주요 요약
제4장 소개
제5장 세계의 유방 병변 위치특정법 시장
제6장 시장 내역 : 유형별
제7장 시장 내역 : 용도별
제8장 시장 내역 : 최종사용자별
제9장 시장 내역 : 지역별
제10장 SWOT 분석
제11장 밸류체인 분석
제12장 Porter's Five Forces 분석
제13장 가격 분석
제14장 경쟁 구도
KSM 26.05.06The global breast lesion localization methods market size reached USD 1,436.8 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 3,010.8 Million by 2034, exhibiting a growth rate (CAGR) of 8.30% during 2026-2034.
Breast lesion localization methods refer to various procedures employed to detect abnormal changes in the breast tissue, also called a breast lesion, caused due to a disease or injury. Some commonly used methods include wire localization, carbon marking, radio-guided occult lesion localization (ROLL), radioactive seed localization (RSL), magnetic seed localization (Magseed), and intraoperative ultrasound (IOUS). These techniques assist doctors and healthcare professionals in making informed decisions and determining the ideal treatment or surgery for the patient. With advancements in surgical, imaging and biomedical technology, breast lesion localization methods have significantly evolved, which is presently driving their demand in the healthcare sector.
BREAST LESION LOCALIZATION METHODS MARKET TRENDS:
A significant increase in breast cancer cases due to changing lifestyles, and unhealthy diets represents the primary factor driving the market growth. Besides this, the growing number of patients requiring lumpectomy and surgical biopsy procedures is augmenting the demand for breast lesion localization methods to ensure accurate removal of the target lesion. Additionally, the governing agencies of various countries are taking favorable initiatives to spread awareness regarding the benefits of early detection of breast cancer. For instance, the Government of Australia launched BreastScreen Australia, a national breast cancer screening program that provides a free mammogram to women aged 50-74 every two years. This, in confluence with the increasing number of government and private reimbursement policies for breast cancer diagnosis, biopsy and other related medical procedures and the launch of innovative breast lesion localization devices by leading players, is catalyzing the market growth. Furthermore, heavy investments in research and development (R&D) activities are offering lucrative opportunities to the market players. Other factors, including the rising number of individuals undergoing cosmetic surgeries like breast enhancement, improving healthcare infrastructure, technological advancements, and increasing consumer healthcare spending, are also creating a positive market outlook.
KEY MARKET SEGMENTATION:
Breakup by Type:
- Wire Localization
- Radioisotope Localization
- Magnetic Tracers Localization
- Others
Breakup by Usage:
- Tumor Identification
- Sentinel Lymph Node Identification
- Lumpectomy
- Mastectomy
Breakup by End User:
- Hospitals
- Diagnostic Centres
- Oncology Clinics
- Ambulatory Surgical Centers
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The report provides a comprehensive analysis of the competitive landscape in the global breast lesion localization methods market with detailed profiles of all major companies, including:
- Argon Medical Devices
- Becton, Dickinson and Company
- BPB Medica - Biopsybell
- Hologic, Inc
- IsoAid, LLC
- IZI Medical Products
- Mdl Srl
- Merit Medical Systems
- Mermaid Medical
- SOMATEX Medical Technologies GmbH
- STERYLAB S.r.l.
- Theragenics Corporation
KEY QUESTIONS ANSWERED IN THIS REPORT
1. What was the size of the global breast lesion localization methods market in 2025?
2. What is the expected growth rate of the global breast lesion localization methods market during 2026-2034?
3. What are the key factors driving the global breast lesion localization methods market?
4. What has been the impact of COVID-19 on the global breast lesion localization methods market?
5. What is the breakup of the global breast lesion localization methods market based on type?
6. What is the breakup of the global breast lesion localization methods market based on the usage?
7. What is the breakup of the global breast lesion localization methods market based on the end user?
8. What are the key regions in the global breast lesion localization methods market?
9. Who are the key players/companies in the global breast lesion localization methods market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Breast Lesion Localization Methods Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 Wire Localization
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Radioisotope Localization
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Magnetic Tracers Localization
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Others
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Usage
- 7.1 Tumor Identification
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Sentinel Lymph Node Identification
- 7.2.1 Market Trends
- 7.2.2 Key Segments
- 7.2.2.1 Lumpectomy
- 7.2.2.2 Mastectomy
- 7.2.3 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Diagnostic Centres
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Oncology Clinics
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Ambulatory Surgical Centers
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Argon Medical Devices
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 Becton, Dickinson and Company
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 BPB Medica - Biopsybell
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Hologic, Inc
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 IsoAid, LLC
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.6 IZI Medical Products
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.7 Mdl Srl
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Merit Medical Systems
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Mermaid Medical
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 SOMATEX Medical Technologies GmbH
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.11 STERYLAB S.r.l.
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.12 Theragenics Corporation
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.1 Argon Medical Devices
